Antiphospholipid antibody associated thrombosis: a consensus for treatment? - Wikidata - awgldk - TriplyDB

Antiphospholipid antibody associated thrombosis: a consensus for treatment?

Antiphospholipid antibody associated thrombosis: a consensus for treatment?

http://www.wikidata.org/entity/Q41442948

about

Recombinant tissue plasminogen activator for the treatment of cutaneous infarctions in antiphospholipid antibody syndrome: a case report.Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis.Management of thrombosis in the antiphospholipid syndrome.

P2860

Q31011556-EC7ACA01-F5E3-48E2-947A-B74C30DCB0CF Q38553245-B76ECC95-30A9-4643-AE15-1225366CFFA3 Q41197497-D6534B70-43BF-400F-9B34-017F13956750

P2860

Antiphospholipid antibody associated thrombosis: a consensus for treatment?

http://www.wikidata.org/entity/Q41442948

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Antiphospholipid antibody associated thrombosis: a consensus for treatment?

@en

type

label

Antiphospholipid antibody associated thrombosis: a consensus for treatment?

@en

prefLabel

Antiphospholipid antibody associated thrombosis: a consensus for treatment?

@en

P1433

Q41442948-2EED20EF-F03F-4205-A489-353C36C1E5C9

P1476

Q41442948-496B5D57-3C44-4C82-9782-DF3EF478A590

P2093

Q41442948-222D1B68-F752-4F70-B321-311867875871

P2860

Q41442948-03CF7147-C82F-4688-A44F-065A2D8A1535

Q41442948-1D1AE412-FCA8-4554-B57B-300A730D1B8C

Q41442948-21AC35B7-7FE2-4DF7-8318-F32BD9079617

Q41442948-27B0DD87-B3B6-49D1-A7BF-CFD4CB04849F

Q41442948-413EE7CC-ECB7-43D8-9372-259E53559BDD

Q41442948-57A8F762-8C97-42D6-A91E-9693CE22A31C

Q41442948-6AF530A4-9564-4C41-A2D4-F78FB4A125DE

Q41442948-6DD5279F-F738-4E7E-B671-8E68C5AFAEDE

Q41442948-6E7CB56A-6AF1-4F1A-BAC6-CF3E0507208E

Q41442948-72753999-07F8-4808-8708-A4436844CB03

P304

Q41442948-9E499075-8646-45B3-8708-6500DD0A1366

P31

Q41442948-E3FE4CB0-07EF-4327-9B07-A9422625658A

P356

Q41442948-092CF64F-0786-48FE-BE4C-41672BFD1767

P433

Q41442948-6DC47312-67DA-4682-8D9A-160688BBFF3B

P478

Q41442948-E27D6019-5673-46FA-B07D-365D19CCE48F

P577

Q41442948-25E3B1B2-4A77-4476-88E9-D3370037A3FE

P698

Q41442948-DB181574-9B5A-43EF-A9F4-1B6E46933F65

P356

096120339600500602

P1433

P1476

Antiphospholipid antibody associated thrombosis: a consensus for treatment?

@en

P2093

K R McCrae

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.

Thrombosis in patients with the lupus anticoagulant.

Clinical trials on antiphospholipid syndrome: what is being done and what is needed?

Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal

Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment

A prospective study of the incidence of deep-vein thrombosis within a defined urban population.

Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.

P304

560-570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/096120339600500602

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

1996-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9116698

http://www.w3.org/2001/XMLSchema#string